Abstract
Radionuclide imaging in endocrine diseases has been in clinical application for many years. Over the last six decades changes lead to an increasing number of available radionuclides and radiolabeled compounds for imaging endocrine organ/tissue function. Radionuclide imaging provides functional as well as morphological information on affected endocrine organs especially thyroid, parathyroid, and adrenal disorders. Endocrine nuclear medicine includes not only diagnosis but also internal radionuclide therapy. Recently, radiolabeled peptides have also been used for diagnostic and for therapeutic purposes.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Further Reading
Elgazzar AH, Gelfand MJ, Washburn LC, Clark J, Nagaraj N, Cumming D, Hughes J, Maxon HR (1995) 1-123 MIBG scintigraphy in adults a report of clinical experience. Clin Nucl Med 20:147–152
Franklyn JA (2009) What is the role of radioiodine uptake measurement and thyroid scintigraphy in the diagnosis and management of hyperthyroidism? Clin Endocrinol 72:11–12
Helal BO, Merlet P, Toubert ME, Franc B, Schvartz C, Gauthier-Koelesnikov H, Prigent A, Syrota A (2001) Clinical impact of (18) F-FDG PET in thyroid carcinoma patients with elevated thyroglobulin levels and negative (131)I scanning results after therapy. J Nucl Med 42:1464–1469
Lumachi F, Tregnaghi A, Zucchetta P, Cristina Marzola M, Cecchin D, Grassetto G, Bui F (2006) Sensitivity and positive predictive value of CT, MRI and I-123 MIBG scintigraphy in localizing pheochromocytomas: a prospective study. Nucl Med Commun 27:583–588
Mettler FA, Guiberteau MJ (2006) Thyroid and parathyroid. In: Mettler FA, Guiberteau MJ (eds) Essentials in nuclear medicine, 5th edn. WB Saunders, Philadelphia, pp 75–100
Okosieme OE et al (2009) The utility of radioiodine uptake and thyroid scintigraphy in the diagnosis and management of hyperthyroidism. Clin Endocrinol 72:122–127
Sarkar S (2006) Thyroid gland. In: Elgazzar AH (ed) Pathophysiologic basis of nuclear medicine, 2nd edn. Springer, New York, pp 209–221
Spies WG, Wojtowicz CH, Spies SM, Shah AY, Zimmer AM (1989) Value of post-therapy whole-body I-131 imaging in the evaluation of patients with thyroid carcinoma having undergone high-dose 1-131 therapy. Clin Nucl Med 14:793
Taillefer R, Boucher Y, Potvin C, Lambert R (1992) Detection and localization of parathyroid adenomas in patients with hyperparathyroidism using a single radionuclide imaging procedure with technetium-99 m-sestamibi (double-phase study). J Nucl Med 33:1801–1807
Wang W, Macapinlac H, Larson SM, Yeh SD, Akhurst T, Finn RD, Rosai J, Robbins R (1999) [18 F]-2-fluoro-2-deoxy-D-glucose positron emission tomography localizes residual thyroid cancer in patients with negative diagnostic 131I whole body scans and elevated thyroglobulin levels. J Clin Endocrinol Metab 84:2291–2302
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Copyright information
© 2011 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Elgazzar, A.H. (2011). Endocrine System. In: A Concise Guide to Nuclear Medicine. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-19426-9_4
Download citation
DOI: https://doi.org/10.1007/978-3-642-19426-9_4
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-19425-2
Online ISBN: 978-3-642-19426-9
eBook Packages: MedicineMedicine (R0)